Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort

• Main Authors: Ji MH, Callaway NF, Greven MA, Vail D, Moshfeghi DM
• Format: Article
• Language: English
• Published: Dove Medical Press 2020-04-01
• Series: Clinical Ophthalmology
• Subjects: pediatric retina; retina; pediatric ophthalmology
• Online Access: https://www.dovepress.com/telemedicine-follow-up-for-intravitreal-bevacizumab-injection-in-the-s-peer-reviewed-article-OPTH

Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel [phone]Email [e-mail]: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmology